Parthenon backs patient support solutions provider Momentum Life Sciences

Following the investment, Momentum’s existing leadership team will continue as significant shareholders in the company.

2 July 2026•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.